Sign inJoin waitlistJoin the waitlist

Loren Michel

Attending Physician · New York Presbyterian Hospital

Credentials: · · · ·

History

Memorial Hospital for Cancer and allied Diseases
2022–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1991–1994
Icahn School of Medicine at Mount Sinai
1988–1991
Case Western Reserve Univ Sch of Med
1984–1988

Research

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells
Nature · 2001 · First of 10 authors · 640 citations
Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts
Cell Reports · 2013 · 525 citations
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control
Nature · 2004 · 455 citations

ES
Eric Sherman
25 papers
NL
Nancy Lee
23 papers
LD
Lara Dunn
22 papers
Nadeem Riaz
22 papers
Sean McBride
21 papers
YY
Yao Yu
18 papers · 1 as a resident
AH
Alan Ho
16 papers
DG
Daphna Gelblum
16 papers
Marc Cohen
16 papers
Richard Wong
16 papers
Douglas Adkins
15 papers
Ian Ganly
14 papers

Grants

Role of Notch-Egfr Pathway Cooperativity in Basal-Like Breast Cancer
National Cancer Institute · R21
Contact PI · $363.7K · Washington University
2011–2014
The Role of trop2 in Prostate Stem Cell Biology and Tumorigenesis
National Cancer Institute · R21
Contact PI · $353.7K · Washington University
2012–2014
A Resource for Biomedical Mass Spectrometry
National Center for Research Resources · P41
Project lead · $1.1K · Washington University
2006–2007
Analysis of Loss of Function of MAD2 in Mammals
National Cancer Institute · K08
Contact PI · $643.9K · Washington University
2001–2006

Clinical trials

Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2018–2024